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Abstract
Background: Typhoid fever remains a public health problem in Vietnam, with a significant burden in the Mekong River delta
region. Typhoid fever is caused by the bacterial pathogen Salmonella enterica serovar Typhi (S. Typhi), which is frequently
multidrug resistant with reduced susceptibility to fluoroquinolone-based drugs, the first choice for the treatment of typhoid
fever. We used a GoldenGate (Illumina) assay to type 1,500 single nucleotide polymorphisms (SNPs) and analyse the genetic
variation of S. Typhi isolated from 267 typhoid fever patients in the Mekong delta region participating in a randomized trial
conducted between 2004 and 2005.
Principal Findings: The population of S. Typhi circulating during the study was highly clonal, with 91% of isolates belonging
to a single clonal complex of the S. Typhi H58 haplogroup. The patterns of disease were consistent with the presence of an
endemic haplotype H58-C and a localised outbreak of S. Typhi haplotype H58-E2 in 2004. H58-E2-associated typhoid fever
cases exhibited evidence of significant geo-spatial clustering along the So ˆng Ha ˆ
˙
u branch of the Mekong River. Multidrug
resistance was common in the established clone H58-C but not in the outbreak clone H58-E2, however all H58 S. Typhi were
nalidixic acid resistant and carried a Ser83Phe amino acid substitution in the gyrA gene.
Significance: The H58 haplogroup dominates S. Typhi populations in other endemic areas, but the population described
here was more homogeneous than previously examined populations, and the dominant clonal complex (H58-C, -E1, -E2)
observed in this study has not been detected outside Vietnam. IncHI1 plasmid-bearing S. Typhi H58-C was endemic during
the study period whilst H58-E2, which rarely carried the plasmid, was only transient, suggesting a selective advantage for
the plasmid. These data add insight into the outbreak dynamics and local molecular epidemiology of S. Typhi in southern
Vietnam.
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Introduction
The Mekong river delta is located in the south of Vietnam
(Figure 1) in an area of 40,000 square kilometres (12% of
Vietnam’s land mass) and is home to over 20% of Vietnam’s
population. It is the area where the Mekong river divides into
multiple channels and drains into the South China sea. The low-
lying nature of the land and the seasonal fluctuation in water level
make the region particularly vulnerable to flooding. The human-
restricted disease typhoid fever is endemic to the Mekong delta
region [1,2], with a mean incidence of ,80 cases per 100,000
people per year [1,2,3,4]. Salmonella Typhi (S. Typhi), the
bacterium causing typhoid fever, is transmitted human-to-human
in areas with poor sanitation.
The first multidrug resistant (MDR; defined as resistance to
chloramphenicol, ampicillin and co-trimoxazole) typhoid outbreak
in Vietnam occurred in Kien Giang in the Mekong river delta in
1993 [5], and since then the fluoroquinolones have become the
first choice for the treatment of typhoid fever. MDR S. Typhi is
usually associated with self-transferrable IncHI1 plasmids carrying
www.plosntds.org 1 January 2011 | Volume 5 | Issue 1 | e929multiple resistance genes encoded within mobile genetic elements
[6,7,8,9,10]. Between 1994 to 1998, over 80% of S. Typhi strains
isolated in the Mekong delta region were reported to be MDR
[11], and declined to approximately 50% between 2002 and 2004
[5,11,12]. This decline may have been catalysed by the change in
treatment policy and the widespread use of fluoroquinolones (such
as ciprofloxacin and ofloxacin), which are effective against MDR
strains [13,14].
While high-level resistance to fluoroquinolones remains uncom-
mon in Vietnam and other endemic typhoid regions, there has
been a sharp increase in the proportion of S. Typhi isolates that
are resistant to nalidixic acid [11]. Nalidixic acid (Nal) is a
quinolone antimicrobial (the precursor of fluoroquinolones) and
the main mechanism for Nal resistance in S. Typhi is mutation of
the DNA gyrase gene, gyrA [11,15]. S. Typhi strains with Nal
resistance-conferring mutations in the gyrA gene usually have
elevated minimum inhibitory concentrations (MIC) to fluoroquin-
olone antibiotics such as ciprofloxacin (MIC $0.125 mg/ml) [16].
However, these organisms are not resistant according to CLSI
guidelines, which are currently defined by MIC $4 mg/ml to
ciprofloxacin [17]. Even though these strains are not classified as
resistant, they are of clinical importance since typhoid patients
infected with such strains respond less well to fluoroquinolone
therapy [14,15,18,19]. Such patients frequently have a protracted
fever and an increased rate of relapse, compared to those infected
with strains that do not have an elevated MIC to fluoroquinolones
(MIC ,0.125 mg/ml to ciprofloxacin and ,0.25 mg/ml to
ofloxacin) [15,18,19]. Resistance to Nal is therefore often used
as a marker to predict how well a patient will respond to therapy
with fluoroquinolones.
The incidence of typhoid fever has declined in Vietnam.
Between 1991 and 2001 approximately 17,000 cases of typhoid
fever (blood culture confirmed and syndromic cases) were reported
Figure 1. Location of hospitals in the Mekong river delta of Vietnam. (A) Map showing the 8 Vietnamese regions stretching from the Peoples
Republic of China in the north to the Mekong river delta in the south. Highlighted in grey is Mekong river delta (Ðo ˆ `ng Ba ˘ `ng So ˆng Cu
¸¸u Long) region,
which is the southernmost of the eight regions and covers 40,000 km
2. The dotted box corresponds to the area magnified in (B). (B) Map showing a
,22,000 km
2 of the Mekong river delta; highlighted are An Giang province (green) and Dong Thap province (grey). Also highlighted are the
provincial hospitals of An Giang province (x) and Dong Thap (y). The direct distance between the two hospitals is 22.5 km.
doi:10.1371/journal.pntd.0000929.g001
Author Summary
Typhoid fever remains a serious public health issue in
some parts of Vietnam, including the Mekong delta region.
Typhoid is caused by the bacterium Salmonella Typhi,
which is frequently multidrug resistant and shows reduced
susceptibility to fluoroquinolone-based drugs. We assayed
single nucleotide variation in the genomes of S. Typhi
organisms isolated from 267 patients with typhoid fever in
the Mekong delta between 2004 and 2005, and identified
genetically distinct S. Typhi strains. We also detected the
presence of genes or mutations that confer drug resistance
in those strains. We found that the vast majority of typhoid
cases were caused by one of two subgroups of H58 S.
Typhi, referred to as H58-C and H58-E2. The H58-E2 group
appeared to cause an outbreak in 2004, affecting patients
living in a small zone near the Mekong River. The other
group, H58-C, was present throughout the study period
and affected patients living in a broader area of the
Mekong River delta. Most of the H58-C strains were
resistant to multiple drugs and carried a plasmid encoding
multiple resistance genes. However very few H58-E2
strains were multidrug resistant, which may explain why
the strain did not persist after the initial outbreak.
S. Typhi in the Mekong Delta
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[1,2], while only 4,323 and 5,030 annual typhoid fever cases were
reported in 2004 and 2005, respectively (Source: National Institute
of Health and Epidemiology, Ministry of Health, Vietnam).
However, 75% of these cases occurred in the Mekong delta [1,2],
likely associated with high population density and the propensity
of the land to become saturated with floodwaters. In this region,
the occurrence of S. Typhi isolates that are MDR and Nal resistant
severely limits treatment options. More than 95% of S. Typhi
isolated in the Mekong delta are now resistant to Nal, placing a
considerable pressure on the effective use of fluoroquinolones
[11,12]. To compare alternative therapies for typhoid fever
patients infected with strains that are MDR and Nal resistant, a
randomized controlled trial comparing gatifloxacin (a newer 8-
methoxy fluoroquinolone) and azithromycin (a macrolide) was
conducted during 2004–2005 in the Mekong delta region [20].
Typhoid patients (adults and children) were recruited into the
study at three hospitals in the south of Vietnam (details in
Materials and Methods, locations are highlighted in Figure 1B).
Here, we used a high-throughput single nucleotide polymorphism
(SNP) typing assay to investigate the population structure of S.
Typhi collected during the study [20], and to determine the
genetic mechanisms of drug resistance in this S. Typhi population.
Materials and Methods
Ethics statement
The study was conducted according to the principles expressed
in the Declaration of Helsinki and approved by the Institutional
Review Board of the Hospital for Tropical Diseases and the
Oxford Tropical Research Ethics Committee (OXTREC). All
patients provided written informed consent for the collection of
samples and subsequent analysis (written informed consent was
provided by the parents or guardian of children under 18 years of
age).
Patient recruitment
S. Typhi isolates were collected during a multicenter clinical
trial [20] conducted between January 2004 and December 2005 at
(a) the Hospital for Tropical Diseases in Ho Chi Minh City
(n=10), (b) Dong Thap Provincial Hospital, Cao Lanh, Dong
Thap province (n=25) and (c) An Giang Provincial Hospital,
Long Xuyen, An Giang province (n=232). Locations of (b) and (c)
are shown in Figure 1B. Adults and children over 6 months of age
were eligible to be included in the study if they had clinically
suspected or culture-confirmed uncomplicated typhoid fever and if
fully informed written consent had been obtained. Patients were
tested for typhoid carriage (via stool culture) during follow-up
appointments at 1, 3 and 6 months after discharge from hospital.
The 267 isolates presented in this study constitute nearly the full
complement of 287 S. Typhi isolated from culture-confirmed
typhoid patients enrolled in the trial; the recruitment flow for
which is described in detail in [20].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed at the time of
initial isolation by disc diffusion according to Clinical Laboratory
Standards Institute (CLSI) guidelines [17]. Antimicrobial agents
tested were: ampicillin, chloramphenicol, trimethoprim-sulfameth-
oxazole (co-trimoxazole), nalidixic acid, ofloxacin, ciprofloxacin
and ceftriaxone (Oxoid, Basingstoke, UK). Minimum Inhibitory
Concentrations (MICs) for amoxicillin, chloramphenicol, nalidixic
acid, ofloxacin, ciprofloxacin, gatifloxacin, ceftriaxone and
azithromycin were determined by E-test (AB Biodisk, Solna,
Sweden). Multidrug resistance (MDR) of isolates was defined as
resistance to chloramphenicol (MIC $32 mg/mL), ampicillin
(MIC $32 mg/mL) and trimethoprim-sulfamethoxazole (MIC
$8/152 mg/mL). Nalidixic acid resistance was defined by an
MIC $32 mg/mL.
Bacterial isolation and DNA preparation
After initial isolation, S. Typhi was stored at 270uC in a 20%
glycerol solution until required for further analysis and DNA
extraction. To revive frozen organisms, MacConkey and Xylose
Lysine Decarboxylase (XLD) agar plates were inoculated from the
glycerol solution and incubated at 37uC overnight. To ensure
correct identification, colonies were checked using slide aggluti-
nation with serotype specific antisera (Vi, O9) and an irrelevant
antisera as a negative control (O4) (Murex, Dartford, United
Kingdom). Two mL of nutrient broth were inoculated with single
S. Typhi colonies and incubated overnight. Overnight cultures
were centrifuged and S. Typhi DNA was extracted using Wizard
Genomic DNA Purification kit (Promega, USA) as recommended
by the manufacturer’s guidelines. DNA was stored at 220uC.
DNA was quantified using the Quant-IT PicoGreen dsDNA
Reagent and Kit (Invitrogen, UK). S. Typhi DNA concentrations
were adjusted to 50 ng/mL and 250 ng of DNA were pipetted
into 96-well plates. Each 96-well plate contained two isolates in
duplicate and the sequenced S. Typhi isolate CT18 as control for
assay reproducibility.
Determination of chromosomal and plasmid haplotypes
The chromosomal haplotype of S. Typhi isolates was deter-
mined based on alleles present at 1,485 chromosomal SNP loci
identified previously from genome-wide surveys [12,21] and listed
in [22,23]. IncHI1 plasmid haplotypes were determined based on
eight SNPs identified previously [22,24] and resistance gene
sequences were interrogated using additional oligonucleotide
probes (listed in Table S1). All loci were interrogated using a
GoldenGate custom oligonucleotide array according to the
manufacturer’s standard protocols (Illumina), as described previ-
ously [22,23]. A maximum-likelihood phylogenetic tree based on
chromosomal SNPs was constructed using the RAxML software
[25].
Statistical analysis
Clinical data were entered into an electronic database (Epi Info
2003, CDC, Atlanta, USA). For comparison of patient character-
istics according to infecting S. Typhi haplotypes, Kruskal-Wallis
tests were used for analysis of continuous variables (age, length of
stay in hospital, fever clearance time) and logistic regression was
used for categorical variables (presence of symptoms). Odds ratios
were adjusted for duration of fever prior to admission and use of
antibiotics prior to admission by including these variables in the
logistic regression model. Where data was missing for a particular
patient and variable, that patient was excluded from analysis of
that variable (N#35 patients). Two-tailed p-values are reported;
statistical analysis was performed using the R package (http://
www.r-project.org/).
PCR amplification and sequencing of gyrA gene in S.
Typhi
Oligonucleotide primers for the amplification of the quinolone
resistance determining regions in the S. Typhi gyrA gene were as
follows [11]: GYRA/P1 59-TGTCCGAG ATGGCCTGAAGC-
39 and GYRA/P2 59-TACCGTCATAAGTTATCCACG-39.
Predicted PCR amplicon size was 347 bp. PCR was performed
S. Typhi in the Mekong Delta
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45–62uC for 45 seconds and extension at 74uC for 1 minute,
followed by a final extension step at 74uC for 2 minutes. PCR
products were purified and directly sequenced using the CEQ
DTCS - Quick Start Kit (Beckman Coulter, USA) and the CEQ
8000 capillary sequencer. The resulting DNA sequence was
analyzed using CEQuence Investigator CEQ2000XL (Beckman
Coulter, USA). All sequences were verified, aligned and
manipulated using Bioedit software (http://www.mbio.ncsu.edu/
BioEdit/bioedit.html) and compared to other gyrA sequences by
BLASTn at NCBI.
Spatial data collection and analysis
Patient addresses were recorded at the time of hospital
admission. The latitude and longitude of the residences of typhoid
fever patients (to the hamlet/village level) was assigned from the
collected address data using 1/50,000 scale maps (Source:
Cartographic Publishing House and VinaREN, Ministry of
Natural Resources and Environment, Vietnam) and cross-checked
using the websites http://www.basao.com.vn and http://ciren.vn.
Location data was analysed using Quantum GIS version 1.4.0
(http://www.qgis.org/). Locations were colour-coded according to
S. Typhi haplotype and clustering of specific haplotypes was
calculated using the nearest-neighbour analysis function. Nearest-
neighbour analysis examines the distances between each point and
the closest point to it, and then compares these to expected values
for a random sample of points from a CSR (complete spatial
randomness) pattern. Significant clustering was inferred by Z-score
value (standard normal variable) of less than 0; a positive score was
interpreted as dispersion of locations.
Results
S. Typhi population structure
A recently developed typing system, based on the simultaneous
interrogation of 1,485 S. Typhi chromosomal single nucleotide
polymorphisms (SNPs) using a custom Illumina GoldenGate array
[22,23], was used to analyse each of the S. Typhi isolates. This
approach facilitates the unequivocal assignment of isolates to
haplotypes, allowing closely related strains to be distinguished
phylogenetically based on single nucleotide changes. From 287
patients with culture confirmed typhoid fever recruited between
January 2004 and December 2005 [20], 267 S. Typhi were
available for SNP typing. These included 264 S. Typhi isolated
from blood culture at admission [20] one relapse isolate and two
faecal carriage isolates. A total of 24 S. Typhi (23 isolated from An
Giang and one from Dong Thap, randomly distributed through-
out the study period) were not available for SNP typing.
A total of 261 S. Typhi isolates (98%) were of the common H58
haplogroup. The remaining isolates were of haplotypes H1
(isolates BJ105, BJ63, BJ64), H45 (isolate BJ264), H50 (isolate
BJ9) and H52 (isolate BJ3; see Figure 2 and Table 1). The H58 S.
Typhi isolates displayed variation at 10 SNP loci (detailed in [23]),
which differentiated seven distinct sub-H58 haplotypes, shown in
Figure 2. However, 242 (93%) of these isolates belonged to just
three closely related H58 haplotypes, designated C, E1 and E2 in
Figure 2. Phylogenetic distribution of S. Typhi isolates. Grey nodes represent control isolates (labelled by isolate code and haplotype group),
unfilled grey circle indicates tree root, white nodes correspond to non-H58 S. Typhi isolated in this study (labelled with isolate code), black nodes
show H58 isolates. Inset: zoom-in on the H58 haplogroup; grey nodes represent control isolates (labelled by isolate code or haplotype code), unfilled
grey circle indicates tree root; coloured circles indicate nodes corresponding to H58 S. Typhi isolated in this study, node labels are as in the text, node
colours are as in Figures 3–4, node sizes indicate the number of isolates on the scale as indicated by numbered circles.
doi:10.1371/journal.pntd.0000929.g002
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strain AG3, isolated during the study (March 2004) from a typhoid
fever patient living in An Giang province, was sequenced
previously [21]. AG3 belongs to the H58-E2 haplotype, and the
SNPs separating E2 from haplotypes E1 and C were originally
identified by analysis of the AG3 genome. Therefore, the ability to
differentiate within the cluster of 242 S. Typhi isolates was
dependant on the inclusion of strain AG3 in the initial genome
sequencing study used to identify SNP loci [21].
All but one S. Typhi isolated from the blood culture of patients
admitted to An Giang Provincial hospital (231/232), as well as the
two faecal S. Typhi strains isolated from chronic carriers in An
Giang, belonged to the S. Typhi H58 haplogroup. The remaining
S. Typhi isolate BJ264 (see Figure 2) was of the H45 haplotype and
was isolated from a typhoid fever patient who was resident in
neighbouring Can Tho province. One patient at An Giang
Provincial hospital relapsed with symptoms of typhoid fever and
had S. Typhi isolated from blood culture 11 days after the initial
treatment (gatifloxacin) had been completed. The mother of the
patient was found to be a chronic S. Typhi carrier. All three S.
Typhi strains - the patient’s admission and relapse blood culture
isolates and the mother’s faecal isolate - belonged to the S. Typhi
H58-E2 subtype. The patient’s isolates were both MDR and
carried the IncHI1 ST6 plasmid (see below), whereas the mother’s
S. Typhi isolate was plasmid-free and susceptible to all first line
antimicrobials at the time of isolation. All three isolates were Nal
resistant but sensitive to gatifloxacin (MIC 0.19 mg/ml). Stool
cultures were taken at 1 month (96% of patients), 3 months (93%)
and 6 months (44% of follow-up. Chronic faecal carriage of S.
Typhi was detected in only one trial patient. This was a MDR
H58-C strain isolated from stool 6 months after treatment (with
gatifloxacin), which was indistinguishable at all assayed loci from
the patient’s original blood culture isolate. Both isolates were Nal
resistant but sensititve to gatifloxacin (MIC 0.19 mg/ml).
At Dong Thap Provincial Hospital, only 3 of the 25 S. Typhi
isolates did not belong to the H58 haplogroup. Two H1 isolates
(BJ63 and BJ64; Figure 2) were identical at all assayed loci and
were isolated on consecutive days from two patients resident in
Dong Thap. A third H1 strain (BJ105; Figure 2) differed from
BJ63 and BJ64 at 16 chromosomal SNP loci and was isolated in
Dong Thap 14 months after these isolates. Two siblings from
Dong Thap province were admitted on consecutive days in 2004
and were both infected with MDR S. Typhi of the haplotype
H58-C.
Of the ten S. Typhi strains isolated at the Hospital for Tropical
Diseases in Ho Chi Minh City, eight were members of the H58
haplogroup, with patients resident in Ho Chi Minh City (n=4),
Long An (n=1), Kien Giang (n=2) and An Giang (n=1)
provinces, reflecting the larger catchment area of the hospital. The
remaining two S. Typhi were of haplotypes H52 (BJ3) and H50
(BJ9) and were isolated from patients living in Binh Hoa province
and Ho Chi Minh City, respectively.
There was no simple association between S. Typhi haplotype
and patient age, length of stay in hospital, fever clearance time,
vomiting, abdominal pain, hepatomegaly or relapse (Table 2).
However, upon admission, patients infected with S. Typhi
haplotype H58-E2 tended to report lower frequencies of diarrhoea
and headache and higher frequencies of constipation compared to
patients infected with other haplotypes, including H58-C (see
Table 2).
Plasmids and antimicrobial resistance
The GoldenGate assay incorporated probes targeting IncHI1
plasmid sequences, allowing for detection of the presence of
IncHI1 plasmid within the genomic DNA extracted from each S.
Typhi isolate. The assay indicated that a total of 139 S. Typhi
isolates harboured an IncHI1 plasmid. All plasmids were of the
IncHI1 ST6 sequence type [24] and all plasmid-bearing isolates
belonged to the S. Typhi H58 haplogroup (see Table 1). The
MDR IncHI1 plasmid was more common among H58-C isolates
than H58-E2 isolates (86% vs 19%, see Table 1). Of the 139 S.
Typhi isolates giving positive signals for IncHI1 SNP loci, 137
(99%) were classified as MDR by antimicrobial susceptibility
testing conducted at the time of isolation. One other IncHI1-
positive isolate tested positive by GoldenGate assay for the genes
sul1, sul2, dfrA7, tetACDR, strAB, bla and cat (resistance genes;
functions outlined in Table S1) like the MDR isolates, yet had low
MICs for chloramphenicol, ampicillin and trimethoprim-sulfa-
methoxazole. An additional S. Typhi isolate, BJ5, was resistant to
ampicillin and trimethoprim-sulfamethoxazole but sensitive to
chloramphenicol. This was consistent with GoldenGate assay
results, which gave positive signals for the repC replication
initiation gene of IncHI1, resistance genes strAB, bla, sul1, sul2,
dfrA7, but no signal for sequences from the cat gene encoding
chloramphenicol resistance. A further 17 S. Typhi isolates were
recorded as MDR according to their antimicrobial susceptibility
pattern at the time of isolation, but did not test positive for IncHI1
plasmid loci. This likely reflects loss of the IncHI1 plasmid in
culture or storage between the time of isolation and DNA
extraction. The MDR status of the infecting S. Typhi isolate was
not associated with fever clearance time (p=0.3, two-sided T-test)
or treatment failure (p=0.18, Chi
2 test).
Table 1. Antimicrobial resistance pattern of S. Typhi haplotypes.
S. Typhi
Haplotype
Total
(% of all isolates)
Nal resistant (% of
haplotype)
MDR
(% of haplotype)
IncHI1 plasmid
(% of haplotype)
MDR+Nal
(% of haplotype)
H58-C 118* (44%) 117 (99%) 102 (86%) 92 (78%) 102 (86%)
H58-E1 15 (6%) 15 (100%) 15 (100%) 14 (93%) 15 (100%)
H58-E2 109* (41%) 109 (100%) 21 (19%) 17 (15%) 21 (19%)
Other H58 19 (7%) 16 (84%) 16 (84%) 16 (84%) 13 (68%)
Non-H58 6 (2%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Total 267 257 (96%) 154 (58%) 139 (52%) 151 (56%)
All S. Typhi were isolated from blood culture, except two that were isolated from the stools of two chronic carriers.
*Includes one faecal carriage S. Typhi isolate. Nal = Nalidixic acid; MDR = multidrug resistant. Presence of IncHI1 plasmid was inferred from GoldenGate assay results
(all isolates).
doi:10.1371/journal.pntd.0000929.t001
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(Nal). All of these isolates belonged to the H58 haplogroup
(Table 1) and all were susceptible to gatifloxacin, ciprofloxacin and
ofloxacin according to current CLSI guidelines [17]. S. Typhi
haplotypes H58-C, H58-E1 and H58-E2 were uniformly resistant
to Nal, with the exception of a single H58-C isolate which had an
intermediate MIC of 28 mg/mL (resistance defined as MIC
$32 mg/mL). The sequenced H58-E2 isolate AG3 harbours a
mutation changing serine (TCC) to phenylalanine (TTC) at codon
83 in the gyrA gene (GyrA-Ser83Phe) [21], which is known to
confer resistance to Nal [26]. In the present study we sequenced
the gyrA gene in 223 of the Nal resistant isolates (87%) and found
the same GyrA-Ser83Phe amino acid substitution in all isolates
tested.
Spatial and temporal distribution
Figure 3 shows the spatial distribution of the residences of 160
typhoid patients (this information was not available for the
remaining patients). Of the patients admitted at An Giang
Provincial Hospital and Dong Thap Provincial Hospital, sufficient
address detail to allow for assignment of latitude and longitude was
provided in 61% and 73% of cases, respectively. This represents
50% and 20% of all blood culture confirmed typhoid fever
patients at An Giang Provincial Hospital and Dong Thap
Provincial Hospital, respectively, during 2004–2005. In An Giang,
patients’ homes clustered around the An Giang Provincial
Hospital, but also around the So ˆng Ha ˆ
˙
u branch of the Mekong
river (see Figure 3). Most S. Typhi isolated from patients living
near this point in An Giang province were of the H58-E2
haplotype (orange in Figure 3), and this group demonstrated
significant clustering using nearest-neighbour analysis (n=57, Z-
score =214.145). In contrast, S. Typhi of the H58-C haplotype
were isolated relatively frequently in neighbouring provinces and
had a more sporadic clustering pattern (red in Figure 3). While
isolates from An Giang Provincial Hospital are overrepresented in
this spatial analysis, the apparent increase in typhoid density in An
Giang is consistent with total Typhi isolation rates at the two
hospitals during the study period (284 at An Giang Provincial
Hospital and 90 at Dong Thap Provincial Hospital).
The temporal distribution of S. Typhi haplotypes over 2004 and
2005 is shown in Figure 4. Typhoid fever cases peaked just prior to
the onset of the wet season in each year, as has been observed
previously in this region [1,3] (see monthly rainfall, solid line in
Figure 4). In 2004, H58-E2 and H58-C were both prevalent (62 C,
red in Figure 4; 103 E2, orange in Figure 4), whereas few isolates
of H58-E2 Typhi were observed during 2005 (55 C, 4 E2; see
Figure 4). The decline of H58-E2 may be associated with selection
for the IncHI1 MDR plasmid, which was much more common in
H58-C (Table 1). As Figure 4 highlights, the majority of isolates
collected during the second season were MDR and carried the
IncHI1 plasmid ST6.
Discussion
Our data show the vast majority of S. Typhi isolates (n=261,
98%) isolated from the Mekong delta during the two-year study
period belonged to the H58 haplogroup. Furthermore, 91% of
isolates (n=242) belonged to a single clonal complex of S. Typhi
H58 (nodes C, E1, E2 shown in Figure 2), demonstrating
remarkable homogeneity in the S. Typhi population in this
location during the study period. The observed level of clonal
dominance is greater than that observed in previous haplotyping
studies of local S. Typhi populations. Among 54 S. Typhi isolates
from Jakarta, Indonesia between 1975 and 2005, a total of nine
Table 2. Selected characteristics of typhoid fever patients, based on baseline presentation history and outcomes.
Variable
S. Typhi
H58-E2
Non-H58-E2
S. Typhi
S. Typhi
H58-C
H58-E2 vs all other
S. Typhi (95% CI) p-value Missing data
n=107 n=157 n=117
Age (yrs) 11.9 12.2 12.7 Diff. 20.8 (22.0,1.0) 0.83 0
Time in hospital (days) 13.9 13.7 13.8 Diff. 0.2 (21.0,1.0) 0.74 0
Fever clearance (hrs) 116 115 121 Diff. 1 (212,18) 0.70 2
Constipation 13.6% 5.8% 6.0% OR 2.6 (1.1,6.1) 0.03 1
(adjusted) OR 2.6 (1.1,6.0) 0.03 35
Headache 55.7% 70.1% 70.1% OR 0.54 (0.32,0.90) 0.02 1
(adjusted) OR 0.66 (0.40,1.09) 0.10 35
Diarrhoea 55.1% 72.6% 73.5% OR 0.46 (0.28,0.78) 0.004 0
(adjusted) OR 0.56 (0.34,0.93) 0.02 34
Abdominal pain 51.4% 56.1% 55.6% OR 0.80 0.37 0
(adjusted) OR 0.76 (0.47,1.24) 0.27 34
Vomiting 35.5% 35.5% 35.0% OR 1.03 0.90 0
(adjusted) OR 1.02 (0.61,1.71) 0.93 34
Hepatomegaly 58.5% 52.3% 51.3% OR 1.35 0.23 2
(adjusted) OR 1.30 (0.79,2.14) 0.30 35
Comparisons of selected characteristics among 264 typhoid fever patients (i.e. excluding carriage and relapse isolates). For continuous variables age, time in hospital
and fever clearance, values shown are means and test statistic given is the difference in means (Diff.; mean value for H58-E2 S. Typhi – mean value for non-H58-E2 S.
Typhi). Other variables indicate frequency of symptoms self-reported at time of admission and of clinician-diagnosed hepatomegaly; test statistic is odds ratio (OR) for
H58-E2 S. Typhi vs non-H58-E2 S. Typhi; both crude OR and adjusted OR are reported (adjusted for duration of fever prior to admission and use of antibiotics prior to
admission, using logistic regression). All comparisons shown are for patients infected with H58-E2 S. Typhi vs those infected with other S. Typhi haplotypes (including
H58-C and others); 95% confidence intervals (CI) are given in brackets.
doi:10.1371/journal.pntd.0000929.t002
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accounting for 53% of isolates; the next most frequent haplotype
was genetically distant from H59 and comprised 24% of isolates
[27]. In Kathmandu, Nepal, a collection of S. Typhi isolated from
children hospitalised with typhoid fever in 2005–2006 was
dominated by the H58-G haplotype (66%) but the distant H42
Figure 3. Spatial distribution of S. Typhi isolates by haplotype and year. The spatial distribution of S. Typhi haplotypes surrounding An
Giang provincial hospital in (A) 2004 and (B) 2005. Each point corresponds to the residential location of a typhoid fever patient; colour indicates the
haplotype of the S. Typhi isolate (with or without plasmid): dark orange = H58-E2 with MDR plasmid, light orange = H58-E2 without MDR plasmid,
dark red = H58-C with MDR plasmid, pink, H58-C with MDR plasmid, grey = other S. Typhi haplotypes. Locations of the hospitals are indicated by a
white cross on a red background; pink circle indicates a radius of 15 km from An Giang Provincial Hospital; arrow indicates the So ˆng Ha ˆ
˙
u branch of
the Mekong river.
doi:10.1371/journal.pntd.0000929.g003
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S. Typhi isolated between 2001 and 2008 in Nairobi, Kenya, 87%
were H58, although two distinct subtypes (nodes B and J, see
Figure 2) were co-circulating at equally high frequencies (.40%
each) between 2004 and 2008 [22]. S. Typhi H58 nodes B and J
(co-circulating in Nairobi) represent distinct lineages, each
acquiring unique SNPs since the last common ancestor of H58
(Figure 2). However H58 nodes C, E1 and E2, which account for
91% of isolates in this study in Vietnam, are closely related and
formed a tight clonal complex differentiated by just two SNPs
(Figure 2). Thus the overall level of clonality of the S. Typhi
population analysed in this study was unexpectedly high. The
clonal complex comprising H58-C, -E1 and -E2 was not detected
in study populations in Nepal and Kenya where the same SNP
typing method was used [22,23], suggesting it may have arisen
locally in Vietnam.
Despite the genetic homogeneity we observed, the availability of
whole-genome sequence data for S. Typhi H58-E2 isolate AG3
[21], collected during the study, allowed us to differentiate closely
related organisms within the H58 group. Just two SNPs identified
in strain AG3 subdivided the homogeneous group into three nodes
C, E1 and E2 (Figure 2), of which two (C and E2) were dominant
(.40% each). Isolates belonging to the H58-C node were present
at a constant rate during the two years of the study (62 isolates in
2004 and 55 in 2005). However, isolates belonging to the H58-E2
node were common during 2004 (103 isolates), yet were virtually
undetected in 2005 (3 isolates). This change in both haplotype
distribution and total number of typhoid cases from 2004 to 2005
is striking, and suggests an outbreak caused by S. Typhi H58-E2
during 2004. We additionally found that H58-C strains had a
much stronger association with the ST6 IncHI1 MDR plasmid
than H58-E2 (Table 1). We speculate that the persistence of H58-
C strains and the corresponding disappearance of H58-E2 may be
associated with a competitive phenotypic advantage conferred by
the IncHI1 MDR plasmid. However, it is important to remember
that node C is a precursor of node E2 and we can only
differentiate E2 from C because we had whole genome sequence
data for an H58-E2 strain from which to identify SNPs [21]. Thus
the population of S. Typhi isolates assigned to node C by our SNP
typing assay may be more diverse than that assigned to H58-E2. It
is also important to note that since our data covers just two years, it
is possible that any competitive advantage of H58-C strains may
be short-lived and there is no evidence for long-term replacement
of H58-E2.
We identified two cases of chronic faecal carriage of S. Typhi
during the course of the study, one in a patient’s relative and one
in a patient after 6 months of follow-up. This underlines the
importance of screening procedures to identify carriers and
effective treatment to eliminate carriage and reduce transmission.
The faecal S. Typhi isolates were of the dominant H58-E2 and
H58-C haplotypes, respectively. In a previous case-control study
performed in the Mekong delta, close contact with a patient with
Figure 4. Monthly incidence of typhoid cases by haplotype. Bar heights indicate the total number of S. Typhi isolated each month during the
study, according to the scale given on the left-hand y-axis; colours indicate the combination of S. Typhi haplotype and presence of IncHI1 ST6 plasmid
as given in the legend. Solid black line = total rainfall each month recorded in An Giang, dashed line = maximum rainfall occurring in a 24 h period
during each month in An Giang; rainfall scale is shown on the right-hand y-axis.
doi:10.1371/journal.pntd.0000929.g004
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disease compared to hospital controls (adjusted odds ratio (OR)
=5.2, 95% confidence interval (95% CI) [1.7, 15.9]) or
community controls (adjusted OR =11.9, 95% CI [2.3, 60.7])
[28].
We were able to collect residential location data from 160
typhoid patients (61%). While typhoid patients reporting to An
Giang Provincial Hospital are overrepresented in this data set
(50% of all confirmed cases vs. 20% of all confirmed cases at Dong
Thap Hospital), the apparent clustering in An Giang (Figure 3) is
consistent with the overall isolation rates at the two hospitals,
which during the study period was more than three times higher at
An Giang Provincial Hospital than Dong Thap Hospital. The data
set provides roughly equal representation of patients infected with
S. Typhi H58-C (65%) and H58-E2 (62%), thus any differences in
spatial distribution between patients presenting at the different
hospitals should not affect the differences between spatial
distribution of these haplotypes. Spatial clustering of S. Typhi
H58-E2 was evident particularly around the So ˆng Ha ˆ
˙
u branch of
the Mekong river, while other S. Typhi haplotypes were more
broadly distributed (Figure 4). The spatial clustering of H58-E2 S.
Typhi further supports a localised outbreak in 2004 caused by
these isolates. In contrast, the broader spatial and temporal
distribution of S. Typhi H58-C during the study suggests it may be
well established in the community and can persist over longer
distances and time periods.
We also observed that some symptoms reported by patients
infected with H58-E2 S. Typhi differed from those infected with
other S. Typhi haplotypes (Table 2). After adjusting for antibiotic
use and duration of fever prior to admission, patients infected with
H58-E2 S. Typhi were more likely to report diarrhoea and
headache compared with other S. Typhi haplotypes (OR =0.56,
95% CI [0.34, 0.93] and OR =0.66, 95% CI [0.40, 1.09],
respectively), but were more commonly associated with constipa-
tion (OR =2.6, 95% CI [1.1, 6.0]). This suggests there may be
some phenotypic differences between H58-E2 and other S. Typhi
with respect to disease, however these were post-hoc analyses and
no adjustments were made for multiple comparisons, hence these
associations should be interpreted with caution. However if
confirmed in subsequent prospective studies, it would be of
interest to know whether these phenotypic characteristic were
associated with specific mutations in H58-E2 S. Typhi. The two
SNPs differentiating the E2 node from E1 and C are both
synonymous mutations (C-.Ti nmelA (nt 315); G-.Ai nrbsA (nt
576)) and our earlier analysis of the AG3 sequence data detected
no phage insertions and no large deletions that were not also
detected in other sequenced H58 isolates [21]. However, we were
unable to verify if other single-base insertions or deletions were
present, which may result in gene inactivation with corresponding
phenotypic effects.
Patterns of antimicrobial resistance of S. Typhi tend to vary
markedly between different typhoid-endemic regions. In this
present work, as in the recent study of Kenyan isolates [22], there
were high rates of MDR associated with IncHI1 ST6 plasmids
among strains of the S. Typhi H58 haplogroup. This suggests that
the presence of the plasmid may contribute to the success of the
dominant S. Typhi haplotypes, and the results of our study
corroborate this hypothesis. The S. Typhi H58-E2 subtype (which
was generally not associated with a plasmid) was only transient,
while the H58-C subtype (which was more commonly associated
with the IncHI1 MDR plasmid) was present in 2004 and 2005 in
southern Vietnam. In Kenya, almost all isolates of the dominant
H58 haplotypes carried the MDR plasmid, while the plasmid-free
H58-G subtype was only detected twice [22]. All the H58 isolates
analysed in the present study were resistant to Nal, conferred by an
identical mutation in gyrA. This is consistent with previous studies
reporting strong associations between the Nal resistance pheno-
type and the H58 haplogroup of S. Typhi [12,22,23]. The
presence of the same mutation conferring Nal resistance in all
isolates of H58-C, -E1 and -E2 suggests this mutation may have
arisen in the common ancestor of this clonal complex, perhaps in
situ in the Mekong delta region, and its continued presence is
likely maintained by selective pressure exerted by the use of
fluoroquinolones.
Conclusions
During 2004–2005, typhoid in the Mekong river delta region of
Vietnam was almost exclusively caused by a single Nal-resistant
clonal complex of S. Typhi. This reflects a higher level of clonality
than observed in other localised S. Typhi populations studied to
date, which may be indicative of higher transmission rates in this
location. The high level of Nal resistance and multidrug resistance,
frequently in the same strains, is concerning and continues to pose
problems for the successful treatment of typhoid fever.
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